UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046376
Receipt number R000052921
Scientific Title Comparison of vaginal and intestinal bacteria between patients with recurrent cystitis and patients with non-repetitive cystitis and patients with non-cystitis in postmenopausal women
Date of disclosure of the study information 2021/12/14
Last modified on 2024/12/16 10:15:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of vaginal and intestinal bacteria between patients with recurrent cystitis and patients with non-repetitive cystitis and patients with non-cystitis in postmenopausal women

Acronym

Comparison of vaginal and intestinal bacteria between cystitis and non-cystitis patients in postmenopausal women

Scientific Title

Comparison of vaginal and intestinal bacteria between patients with recurrent cystitis and patients with non-repetitive cystitis and patients with non-cystitis in postmenopausal women

Scientific Title:Acronym

Comparison of vaginal and intestinal bacteria between cystitis and non-cystitis patients in postmenopausal women

Region

Japan


Condition

Condition

Postmenopausal patients visiting an outpatient urology department

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to compare the vaginal and intestinal bacteria of patients with recurrent cystitis, patients with non-repetitive cystitis, and patients with non-cystitis to determine whether patients with recurrent cystitis can be predicted.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Differences in vaginal and intestinal flora in patients with recurrent cystitis, patients with non-repetitive cystitis, and patients with non-cystitis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.Female patients who visit the urology outpatient department between December 31, 2025 after the approval of the Ethics Committee
2.Patients who can voluntarily obtain consent to participate in the research in writing from the patient
3.Patients who are menopausal at the time of obtaining consent

Key exclusion criteria

1.A woman whose vagina and anus are closed
2.Patients with uterine cancer who have not been hysterectomized and are being treated
3.Patients being treated for vaginitis
4.Patients who have difficulty opening their legs

Target sample size

45


Research contact person

Name of lead principal investigator

1st name AYANO
Middle name
Last name ISHII

Organization

Okayama University Hospital

Division name

Integrated Support Center for Patients and Self-learning

Zip code

700-8558

Address

2-5-1,Shikata,Kita-ku,Okayama

TEL

0862357844

Email

ishii-a@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name AYANO
Middle name
Last name ISHII

Organization

Okayama University Hospital

Division name

Integrated Support Center for Patients and Self-learning

Zip code

700-8558

Address

2-5-1,Shikata,Kita-ku,Okayama

TEL

0862357844

Homepage URL


Email

ishii-a@cc.okayama-u.ac.jp


Sponsor or person

Institute

Department of Urology,Okayama University Graduate School of Medicine,Dentistry and Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee

Address

2-5-1,Shikata,Kita-ku,Okayama

Tel

0862356938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 10 Month 26 Day

Date of IRB

2022 Year 01 Month 07 Day

Anticipated trial start date

2022 Year 01 Month 13 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Insert a thin cotton swab into the patient's vagina or rectum and wipe the secretions with a cotton swab to investigate the bacteria present in the specimen. We will investigate the difference in vaginal and intestinal bacterial flora by the next-generation sequencer and the difference in pathogenicity of E. coli in the intestine by experiments.


Management information

Registered date

2021 Year 12 Month 14 Day

Last modified on

2024 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052921